Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial

CONCLUSIONS: The Ayurveda interventions, Ashwagandha and Shunthi, can effectively reduce the duration of clinical recovery and improve time for viral clearance in mild and moderate COVID-19 is safe and well-tolerated during the duration of the trial.TRIAL REGISTRATION: Clinical Trial Registry of India - CTRI/2020/08/027224.PMID:37482107 | DOI:10.1016/j.ctim.2023.102966

Source: Complementary Therapies in Medicine - July 23, 2023 Category: Complementary Medicine Authors: Harbans Singh Babita Yadav Amit K Rai Sumit Srivastava Ajv Saiprasad Sophia Jameela Richa Singhal Sanuj Muralidharan Rijin Mohan Shikha Chaudhary Rakesh Rana Shruti Khanduri Bhagwan S Sharma Bhogavalli Chandrasekhararao Narayanam Srikanth Kartar S Dhiman Source Type: research